Your session is about to expire
← Back to Search
Advanced Rehabilitation Technology for Neurological Disorders
N/A
Recruiting
Led By Brett Schoen, MD
Research Sponsored by Rehabilitation Hospital of Overland Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial compares using robotic devices & advanced tech with traditional rehab to improve outcomes for people w/ neurological diagnoses and save money.
Who is the study for?
This trial is for adults over 18 with neurological disorders who are in inpatient rehab and can stay at least 7 days. They must be able to communicate, follow commands, fit into a device, and tolerate certain positions. Excluded are those with conditions limiting study benefits or involved in another study.
What is being tested?
The study tests if using robotic devices like Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics during rehab gives similar or better results than standard therapy alone. It's randomized: some get technology-assisted therapy; others don't.
What are the potential side effects?
Potential side effects may include discomfort from fitting into the devices or fatigue due to increased intensity of rehabilitation sessions. There might also be risks specific to each device used.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Neuro-QOL
Secondary study objectives
10 Meter Walk Test
Areas of pain
Cost of caregiver burden
+13 moreOther study objectives
Goal attainment scale (GAS)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Inpatient Rehabilitation with ARTExperimental Treatment1 Intervention
Inpatient rehabilitation with advanced rehabilitation technology
Group II: Inpatient Rehabilitation without ARTActive Control1 Intervention
Inpatient rehabilitation without advanced rehabilitation technology
Find a Location
Who is running the clinical trial?
Rehabilitation Hospital of Overland ParkLead Sponsor
Discovery StatisticsUNKNOWN
Brett Schoen, MDPrincipal InvestigatorRehabilitation Hospital of Overland Park
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I can communicate pain, stop a session if needed, and follow simple instructions.I am currently in inpatient rehab at Overland Park for a neurological condition.I can use at least one medical device.I can sit or stand without feeling dizzy or faint.I have no other health conditions that could interfere with the study.
Research Study Groups:
This trial has the following groups:- Group 1: Inpatient Rehabilitation with ART
- Group 2: Inpatient Rehabilitation without ART
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger